Understanding Semaglutide and Its Benefits Semaglutide is FDA-approved for chronic weight management and comes under brand names like Wegovy for weight loss and Ozempic for diabetes
Patients should always inform their healthcare providers about any medications theyre on
Research shows that without continued treatment or significant lifestyle reinforcement, patients may regain 30 to 50 percent of lost weight within one year of discontinuation, though individual timelines differ based on genetic factors, baseline metabolism, and behavioral modifications sustained during therapy
Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications originally developed for type 2 diabetes management
However, its not necessarily that simple for everyone
Gastrointestinal complaints were most common, including [1, 12]: Indigestion Constipation Nausea Diarrhea Abdominal pain Vomiting These outcomes were dependent on dosage and timing, likely caused by alterations in gastric motility and intestinal uptake